I Insilico Medicine
Updates & Highlights
Yahoo Finance UK · 1 day ago
InSilico Medicine Cayman TopCo (3696.HK) stock price, news, quote and history
Forbes · 1 day ago
How Insilico Medicine Is Using AI To Reinvent Drug Discovery
Insilico Medicine · 2 days ago
Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging
Recent Openings
View all 3 jobs arrow_forwardMachine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
All Jobs
Machine Learning Engineer (LLM Architect – Target ID) (UAE)
location_on Remote, GB
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Remote Work
Work from anywhere flexibility
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Insilico Medicine?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentInSilico Medicine Cayman TopCo (3696.HK) stock price, news, quote and history
InSilico Medicine Cayman TopCo (3696.HK) stock price, news, quote and history
Yahoo Finance UK · 1 day ago
How Insilico Medicine Is Using AI To Reinvent Drug Discovery
How Insilico Medicine Is Using AI To Reinvent Drug Discovery
Forbes · 1 day ago
Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging
Insilico Medicine Nominates ISM9077, Potential First-in-class Target Y Inhibitor, as Preclinical Candidate (PCC) for Ocular Diseases, Inflammatory Disorders and Aging
Insilico Medicine · 2 days ago
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
News-Medical · 4 days ago
Insilico Medicine launches AI drug discovery benchmarking platform
Insilico Medicine launches AI drug discovery benchmarking platform
Drug Target Review · 8 days ago
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science
Insilico Medicine · 8 days ago
Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma
Insilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma
Insilico Medicine · 10 days ago
Insilico Medicine to present phase 1 data for AI-designed drug
Insilico Medicine to present phase 1 data for AI-designed drug
Investing.com · 12 days ago
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
Insilico Medicine · 12 days ago
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors
Insilico Medicine · 12 days ago
Weekly | Insilico Medicine to join Cure Virtual Dialogue on US–China biomedical competitiveness
Weekly | Insilico Medicine to join Cure Virtual Dialogue on US–China biomedical competitiveness
EurekAlert! · 15 days ago
Insilico Medicine and Bora Pharmaceuticals sign strategic partnership worth up to $2.5 billion
Insilico Medicine and Bora Pharmaceuticals sign strategic partnership worth up to $2.5 billion
MedTech World · 16 days ago
Insilico Medicine nominates ISM9528 non-opioid chronic pain candidate using AI
Insilico Medicine nominates ISM9528 non-opioid chronic pain candidate using AI
Drug Target Review · 16 days ago
Targeting the $100 Billion Market: Insilico Medicine Nominates AI-driven Novel PCC ISM9528 for Pain Management
Targeting the $100 Billion Market: Insilico Medicine Nominates AI-driven Novel PCC ISM9528 for Pain Management
Insilico Medicine · 17 days ago
Weekly Events | Insilico Medicine executives at CPIC: navigating the dual breakthrough of tech innovation and clinical validation in AI drug discovery
Weekly Events | Insilico Medicine executives at CPIC: navigating the dual breakthrough of tech innovation and clinical validation in AI drug discovery
EurekAlert! · 22 days ago
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals
Pharmaceutical Executive · 24 days ago
Insilico Medicine, Bora Pharmaceuticals Form AI Drug Discovery Alliance
Insilico Medicine, Bora Pharmaceuticals Form AI Drug Discovery Alliance
Moomoo · 24 days ago
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
Insilico Medicine · 24 days ago
Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration
Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration
Pharmaceutical Executive · 26 days ago
Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
Deepening Collaboration in AI-Powered R&D Acceleration: Insilico Medicine and CMS announce additional collaborations in CNS diseases
Insilico Medicine · 26 days ago